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Abstract 
Surgery and anesthetics may cause brain damage, and the resulting 
neurological defect can impair the patient's cognitive function. This disorder is 
one of the most common complications after surgery and causes disorders in 
several cognitive areas of the patient. The mechanism of this disorder is not 
fully understood, but neuronal inflammation is one of the main causes of this 
disorder. The purpose of this systematic review was to evaluate 
neuroprotective drug strategies for the treatment or prevention of surgical 
disorders associated with anesthesia. We searched the keywords 
"neuroprotective", "neuroprotection", "postoperative" and "perioperative" in 
the databases of the web of science, Scopus, PubMed, ScienceDirect, and 
Google Scholar with a 5-year time limit. At first, 492 articles were obtained, 
and finally, after a detailed survey based on exclusion and inclusion criteria, 
31 studies were selected to extract data. Findings from studies show that 
medication and treatment strategies used in a group of mice and rats under 
surgery with treatment can improve Neuronal inflammation and brain damage 
compared to mice and rats with surgery only and reduce the side effects of 
surgery and anesthetics. 
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Introduction 
Postoperative cognitive dysfunction is a clinical 
complication in the central nervous system that is 
known as one of the most significant postoperative 
complications and causes disorders in several cognitive 
areas such as memory, concentration, learning, and 
speaking disorders Becomes (1). This disorder can 
occur in patients with mild to severe, these disorders 
when are severe and long-lasting may also increase the 
risk of death (2, 3). 
The mechanism of complete cognitive 
dysfunction has not been determined, but the results of 
previous studies showed that neuritis caused by general 
anesthesia and surgery was one of the main causes of 
this disorder (4-7). The results of various clinical 
studies showed that increased levels of serum pro-
inflammatory cytokines might be associated with 
impaired postoperative cognitive function, (8, 9) 
regulation of inflammatory cytokines in the 
hippocampus after surgery, and macrophage 
infiltration. It occurs in the brain and activates the glia 
(10, 11) and by inhibiting macrophages and neuritis, 
cognitive dysfunction is reduced (10). Results of in 
vivo studies showed that there is a link between 
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cognitive dysfunction and neuroinflammation (4, 12-
13). Therefore, neuroinflammation after surgery can 
cause synaptic dysfunction and apoptosis in the 
hippocampus. However, the results of the studies show 
only inflammation. Neurological does not lead to 
cognitive dysfunction (14-16). 
For example, the results of a study by Zhang et 
al. On mice showed that the expression of 
inflammatory mRNA molecules such as TNF-α, IL-1β, 
and IL-6 increased after surgery in mice receiving 
anthocyanin. They inhibit their effects and the 
expression of these molecules was significantly 
reduced. IBA1 was also increased as a microglial 
marker in the hippocampus after surgery, but mice 
receiving anthocyanin were able to inhibit its effect and 
reduce its expression. Hippocampal cell apoptosis was 
also reduced in drug-treated mice, unlike other mice. 
(17).  
In a study by Ye et al., Inhibition of IBA1 
expression and inflammatory mRNA molecules and 
reduced apoptosis of hippocampal neurons were 
observed in operated mice receiving Honokiol (18). 
However, in Zhang et al.'s study, the levels of TNF-α, 
IL-1β, and IL-6 were not significantly different 
between operated mice and operated mice receiving 
lipopolysaccharide (19). 
Results of previous studies showed that neuritis 
could play an important role in the development of 
cognitive dysfunction, therefore, therapeutic and anti-
inflammatory strategies can reduce cognitive 
dysfunction by inhibiting inflammation. The purpose 
of this systematic review study was to review 
neuroprotective strategies for the treatment or 
prevention of surgical disorders. 
This systematic review study was performed 
based on the Prism checklist. To prevent bias in the 
study, the method of searching databases, selecting 
studies based on input and output criteria, evaluating 
the quality of studies based on the ARRIVE checklist, 
and extracting information from studies were 
performed by two researchers independently. The 
opinion of the third researcher applies when there was 




Search Strategy: Keywords "neuroprotective", 
"neuroprotection", "postoperative" and "perioperative" 
were searched in the web databases of science, Scopus, 
PubMed, ScienceDirect, and Google Scholar. Only 
articles published in English were reviewed. First, the 
titles and abstracts of the articles obtained from the 
search were reviewed, and then the articles that were 
selected were reviewed based on the input and output 
criteria so that finally the articles that were eligible to 
extract the required information. A 5-year time limit 
(2016-2020) was set for the search. This systematic 




Study selection: Only articles in English were 
reviewed and articles in other languages were 
excluded. We reviewed human studies, duplicates, 
studies of animals tested for disease (such as diabetes), 
articles that examined only the effects of anesthesia on 
animals without surgery, and a variety of case series, 
case reports, conference abstracts, editorials, letters to 
the editor and commentaries were identified and 
removed from the study. 
 
 
Quality assessment: the methodological quality 
assessment of the selected articles based on the 
ARRIVE guideline  (has been prepared to increase the 
quality of methods and results of experimental and 
laboratory studies on animals) was independently 
reviewed by two reviewers (20). Each of the different 
sections of the study such as title, abstract, 
introduction, methodology, findings, and discussion 
were matched with 20 items of ARRIVE instructions. 
Data extraction and Processing: we extracted the 
species tested, their number, sex, and age, type of 
surgery, anesthetic used, a drug used to evaluate its 
neuroprotective mechanism, doses of the drug used, 
and a summary of results from the studies. One 
reviewer extracted the required information from the 
selected studies and entered it in the table. This 
information was carefully reviewed by the second 
reviewer and in case of disagreement between the first 
and second reviewer, the third reviewer was used. If 
the full text of the article or the required data was not 
available, we sent an email to the author of the article 
requesting the full text of the article or the required data 
to be provided to us for information retrieval. 
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Results 
After searching for keywords in Scopus, Web of 
Science, ScienceDirect, PubMed, and Google Scholar 
databases, we obtained 492 articles for the period 2016 
to 2020. After deleting 114 duplicate articles, 378 
studies remained to review the title and abstract. After 
carefully reviewing the titles and abstracts of 378 
articles, 269 studies due to being human, repetitive, 
non-English language, non-surgical, sick animals, case 
reports, conference abstracts, editorials, letters to the 
editor, commentaries the study was deleted. 109 
articles were selected for more detailed review, the full 
text of 109 articles was carefully reviewed, and finally, 
31 studies were included in the study due to the 
required information, and their information was 
extracted. The article search process and the number of 
selected and deleted articles based on the input and 
output criteria are summarized in the flow diagram 
(Figure 1).  
A summary of the characteristics of 31 
studies, including items of type and number of animals 
tested, type of surgery, anesthesia, the drugs used to 
evaluate the effects on neuroprotection, doses used, 
and also a summary of the results are given in Table1. 
Animals: in 14 studies mice (17-19, 21-31) and 17 
studies Rat (32-48) were used for studies. In most 
studies (83.8%) only males had been used. The reason 
for using males in most studies was to eliminate the 
effect of female sex hormones on cognitive 
dysfunction and also to eliminate weight differences. 
Males weigh were less (30). In 15 studies of Sprague 
Dawley rats, 11 studies of C57BL/6 male mice, and 
each of CD-1 mice, F344XBN F1 rats, Wistar rats, and 
Kunming mice were used once in 31 studies selected 
for testing. 
Anesthesia drugs: data extracted from 31 studies 
showed that in 12 studies, from the anesthetic 
Isoflurane (19, 17, 21-30), 6 studies from the anesthetic 
Sevoflurane (18, 31-35), one study from pentobarbital 
(36), and 4 studies from pentobarbital sodium (37-40), 
chloral hydrate alone (41-44) was used in 4 studies and 
chloral hydrate with lidocaine was used in one study 
(45). In three other studies, anesthetics halothane (46), 
fentanyl in combination with droperidol (47), and 
bupivacaine (48) were used for surgery in mice or rats. 
Anthocyanin: the drug was used in one study, despite 
a significant increase in phosphorylation of MLK3, 
p38 MAPK, and JNK in operated mice compared with 
the control group (P<0.01), both doses of 100 and 50 
mg/kg phosphorylation level in mice undergoing 
surgery and receiving medication, decreased 
significantly (P<0.01).  
Significantly increased expression of the 
protein (IBA-1) molecule 1 ionized calcium-binding 
adapter induced by surgery (P<0.01), decreased 
significantly with each dose (P <0.01). Neuronal 
apoptosis and expression level of pro-inflammatory 
cytokine molecules were also significantly reduced 
after surgery (P<0.01) after receiving treatment 
(P<0.01) (17). 
Fingolimod (FTY720): using this drug in mice 
undergoing surgery significantly reduced the activity 
of microglia in the CA1 region of the hippocampus (p 
<0.05) (21). An abnormal increase in microglia activity 
is directly related to neuroinflammation and increases 
neuroinflammation, thus increasing the likelihood of 
cognitive dysfunction (4). Syn, psd95, and ampar 
proteins, which are glur2 subunits, are involved in 
postoperative cognition. Glur2 and psd95 protein 
levels should be significantly reduced after surgery (p 
<0.05) with Fingolimod (fty720). Increased 
significantly (p <0.05). However, the level of Syn 
protein did not change much after surgery (p> 0.05) 
and also the administration of the drug did not affect 
its level (p> 0.05) (21). 
RO 61-8048: macrophages activated by immune 
cytokines that result from postoperative brain damage 
stimulate the production of kynurenine in the brain, 
which binds kynurenine to its target receptors in 
microglia and astrocytes to produce kynurenic acid 
(KYNA) and quinolinic acid (QUIN) becomes. QUIN 
can cause nerve poisoning. QUIN increased 
significantly after surgery (p <0.01) while receiving 
RO 61-8048 in these rats could significantly reduce its 
expression (p <0.01). KYNA expression also increased 
significantly after surgery compared to the control 
group (p <0.01) and also received treatment 
significantly increased its expression compared to rats 
who underwent surgery and did not receive treatment 
(p <0.01). Pro‐apoptotic Bax markers were 
significantly decreased (p <0.01) using RO 61-8048 
treatment and also anti‐apoptotic BCLxl and BCL2 
markers were significantly increased (p <0.01) (32). 
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Table 1. Characteristics of studies with neuroprotective strategies 
Ref Outcome Doses Drug/inhibitor Anesthesia drug Surgery Animal 
(Number) 
ID 
(17)  phosphorylation of MLK3, p38 MAPK, and JNK in 
the hippocampus ↓ 
 IBA1 protein expression level ↓ 
 apoptotic cells ↓ 
 mRNA expression levels of inflammatory molecules 

























(21)  activated microglia in CA1 at 6 hours and 3 days after 
surgery ↓ 
 The expression of PSD95 and GluR2 protein ↑ 
 The expression of SYN protein ▬ 
1 mg/kg Fingolimod (FTY720) 
 





(32)  expression of QUIN ↓, KYNA expression ↑, pro‐
apoptotic BAX ↓ , and anti‐apoptotic markers BCLxl 










(33)  the concentration of IL-β, IL-6, and TNF-α ↓ 
 IBA-1 positive cells in hippocampus and prefrontal 
cortex ↓ 
 The content of Aβ and Tau in the hippocampus, 
prefrontal cortex, and plasma ↓ 
 apoptotic cells in the hippocampus and prefrontal 
cortex ↓ 
 expression of Bax, Bcl-2, and Caspase-3 in the 
hippocampus, prefrontal cortex ↓  









(34)  expression levels of GRP78 and eIF2a in the 
hippocampus ↓ 
 Beclin-1, Bax↓ , and Bcl-2 levels ↑ 
12 ml vitamin-rich 
carbohydrate 
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(35)  expressions of TNF-α and IL-1β ↓ 
 ameliorated in neuronal morphology and arrangement 
 neuronal apoptosis index in the hippocampal CA1 
region ↓ 
 the protein expressions of GABABR1 and GABABR2 
↓, PKA, BDNF, and p-CREB ↑, CREB ▬ 






(36)  the protein level of NF-κB p65 and IL-1β at 7 days 
after surgery ↓  
 protein expression of GLP-1 and GLP-1R ↑, Iba-1 ↓, 
and p-GSK-3β ↑ in the hippocampus at 7 days after 
surgery  
 synaptophysin expression in the hippocampus at 7 
days after surgery ↑ 
 levels of tau hyperphosphorylation at Ser396 and 
Ser199/202 ↓ 







(22)  TNF-α and IL-6 cytokine expression level ↓ TNF-α 
and IL-6 transcription levels ↓ 
 phosphorylation of ERK, JNK, P38, and P65↓ 
 The cell body-to-cell size ratio ↓ 
 decreasing the activated level of IBA1-positive cells 





(23)  expression levels of LC3-II and Beclin-1 ↑ 
 PINK1 and Parkin protein expression ↑ 
 The levels of MDA and Mitochondrial ROS ↓ 
 expression of NLRP3, ASC, Caspase-1, IL-1β IL-18, 
and Iba-1 ↓ 
 neuronal apoptosis in the hippocampal CA1 and DG 
regions ↓ 







(18)  neuronal apoptosis in the hippocampal CA1 and CA3 
regions ↓ 
 expression levels of TNF‐α, IL‐1β,  MCP‐1, and IBA-
1 in the hippocampus  region↓ 
 level of MDA,  Mitochondrial ROS, and cytochrome C 
↓ 
 expression levels of SIRT3 ↑, Ac ‐ SOD2 ↓ and SOD2 
▬ 







(24)  levels of ROS ↓ 
 basal mitochondrial respiration levels ↑ 
 ATP production ↑ 
 maximal mitochondrial respiratory capacity↑ 
 uncoupling capacity↑ 
 levels of mitochondrial membrane potential↑ 
 sirt3 expression and deacetylation activity↑ 
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(37)  the protein expression of Shh, LC3-II, LC3-II / LC3-I 
↑ , and P62 ↓ 
15 mg/kg purmorphamine chloral hydrate intramedullary 








(25)  regulation of IL-6 and IL-1β in high dose ↓ and low 
dose ▬ 
 regulation of IL-8 and TNF- α in all doses ▬ 
 phosphorylation of JNK and p65 in high dose↓ and ▬ 
low dose 
 Tau phosphorylation in the hippocampus at all doses↓  
0.75 g/kg (low 
dose)  
1.5 g/kg (high 
dose) 




(38)  Hippocampal IL-1β gene and protein expression in 
aged rats ↓ 
 upregulated IL-4, Arginase1↑ , and NFKBIA↓ mRNA 
expression in aged rats  
 CD3↓ , CD4 ▬ , and FOXP3↑ mRNA expression in 
aged rats 
0.1 mg Mycobacterium vaccae 
immunization 
halothane laparotomy  aged male 
F344XBN 
F1 rats (-)  
14 
(39)  levels of hippocampal IL-1 β and TNF- α↓ at 80, 60 
and 40 mg/kg doses 
 levels of hippocampal IL-1 β and TNF- α ▬ at 20 and 






emulsified form of 
resveratrol 





(40)  The number of DCX positive cells in the DG of the 
hippocampus ↑ at all doses 
 Levels of IL-1β and IL-6 and TNF-α gene expressions 
↓ at all doses 
 BDNF gene and protein expression ↑ at all doses 
 p-CREB/CREB and PKA production ↑ at all doses 
 p-MAPK/MAPK ratio ↓ at all doses 
3 μg/kg 
 12 μg/kg 







(41)  the protein expression levels of the pro-inflammatory 
cytokines IL-1β, TNF-α, HMGB-1, and NF-κB p65 in 
the hippocampus at 1 and 3 days after surgery ↓ 
 levels of IL-1β↓ , TNF-α ▬  , and HMGB-1↓ at 1 day 
and 3 days after surgery 
 BDNF and p-TrkB expression in the hippocampus ↑ at 
1 day and ▬ 3 days after surgery 
 expression of cleaved caspase-3 in the hippocampus ↓ 
at 1 and 3 days after surgery 
 neuron Apoptosis in the CA1 Region ↓ at 1 and 3 days 
after surgery 
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(42)  hippocampal neuroapoptosis and  [Ca2+)i rate ↓ at 1 
and 7 days after surgery 
 The expression of CaN and caspase-3 ↓ at 1 and 7 days 
after surgery 








(19)  Levels of TNF‑α ↓ , IL-1β ↓, IL-6 ↓ , and IL-10 ▬ at 
24 hours after surgery (LPS administration at 72 h and 
24 h before surgery) 
 Levels of TNF‑α ▬ , IL-1β ▬, IL-6 ▬ , and IL-10 ▬ 
at 24 hours after surgery (LPS administration at 6 h 
and 0 h before surgery) 
 the number of hippocampal IBA1 positive cells in the 
hippocampus ↓ (LPS administration at 72 h and 24 h 
before surgery) 








(26)  The expression of P2X7 receptors, precursor caspase 1 
and P20 ↓ at 6 hours and 7 days after surgery  
 Levels of Iba-1 in the DG and CA1 region ↓ at 6 hours 
and 7 days after surgery  







(43)  Levels of TNF-α ▬, IL-1β↓, IL-6↓, and HMGB1↓in 
serum and hippocampal 
 Caspase-3 activity ↓  






(27)  Levels of TNF-α ↓ and IL-1β ↓ in hippocampal at 8, 
10, and 14 days after surgery  
 the activity of NF-κB ↓ in hippocampal at 8, 10, and 
14 days after surgery 
 The optical density of TNF-α ↓ and IL-1β ↓ in 
hippocampal at 8, 10, and 14 days after surgery 





(28)  neuronal death in the hippocampal region ↓ 
 the expression of GRP78 ↓ and CHOP↓ 
 neuron apoptosis in the hippocampal region ↓ 






(44)  neuronal apoptosis in the Hippocampal tissues ↓ 
 the expression of Caspase-3 ↓ at 3 and 6 hours after 
surgery  
 serum levels of S100β ↓, TNF-α ↓ and IL-6 ↓ at the 
end of the surgery, 3 and 6 hours after surgery 
 the expression of p-Akt ↑  and p-GSK3β ↑ 
0.8 mg/kg α7nAchR agonist 
PHA568487 
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 the expression levels of total Akt ▬ and total GSK3β 
▬ 
(45)  Apoptosis and [Ca2+]i rate of hippocampus neurons ↓ 
at 1 and 7 days after surgery  
 Expression of Bax↓ and Bcl-2 mRNA↑ at 1 and 7 days 
after surgery 
 Bax/Bcl-2 ratio ↓ at 1 and 7 days after surgery 
 the nuclear condensation, chromatin margination, 
mitochondrial vacuolization, and  endoplasmic 
reticulum swelling were  attenuated at 1 and 7 days 
after surgery 
 
 Apoptosis and [Ca2+]i rate of hippocampus neurons ↓ 
at 1 and 7 days after surgery  
 Expression of Bax↓mRNA at 1 day after surgery 
  Bcl-2 mRNA↑ at 1 and 7 days after surgery 
 Bax/Bcl-2 ratio ↓ at 1 and 7 days after surgery 
 the nuclear condensation, chromatin margination, 
mitochondrial vacuolization, and  endoplasmic 





 4 ml/kg 
Nimodipine 
 







(29)  levels of HMGB1 and TLR4 protein ↓ in the 
hippocampus of the aged mice 
 expression of synapsin I ▬ and PSD95 ↑ in the 
hippocampus of the aged mice 
 levels of the nuclear ↓ and cytosolic protein NF-κB ↑ 
in the hippocampus of the aged mice 
 Levels of IL-1β↓, TNF-α↓, and IL-6↓ in the 
hippocampus of the aged mice 
 levels of p-Tau at the site of AT-8 and Ser396 in the 
aged mice ↓ 
 levels of BACE1↓ in the aged mice 
 levels in either soluble Aβ40 and Aβ42 fraction or 
formic acid-extracted fraction ↓ 
60 mg/kg  
 
glycyrrhizin isoflurane Splenectomy Adult (9-
month-old) 





(46)  concentrations GDNF↑ and BDNF ▬ in the 
hippocampus  
 cells positive for both BrdU and NeuN ↑ 
 expression of Iba-1 ↓ 
- Pyrrolidine 
dithiocarbamate 
sevoflurane The surgery was a 
right carotid artery 
exposure 
Postnatal 
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(47)  (high dose): levels of S100β↓and NSE↓ in plasma at 1 
and 2 hours after surgery  
 (low dose): levels of S100β↓ and NSE↓ at 2 hours after 
surgery 
 The apoptosis rate of hippocampal CA1 and cortex  
region neurons ↓ at all doses 
 Levels of IL-6↓ and IL-10 ▬ in the cortex region at all 
doses 
 (all doses): levels of IL-6↓at 2 hours after surgery and 
IL-10 ▬ at 1 and 2 hours after surgery in plasma  
 expression of the cleaved caspase-3 protein↓ in the 
hippocampus  at all doses 
 expression of pJAK2↓ and pSTAT3 ↓proteins in the 
hippocampus at all doses 
  
5 μg/kg (high 
dose) 
2.5 μg/kg (low 
dose) 








(30)  Levels of IL-1 β, TNF- α, IFN-γ, and Iba-1 in the 
hippocampus ↓ 
 Levels of IL-4 and IL-10 ↑ 
45 mg/kg minocycline pentobarbital sodium appendectomy Aged mice 
(120) 
29 
(48)  Iron concentration in hippocampal ↓ 
 The expression of ferritin↓, Caspase-3↓, Bax ↓at 1,3 
and 7 days after surgery and Bcl-2↑ at 1 day after 
surgery  
 numbers of positive-cell in DG, CA1, and CA3  region 
↓ 
 The average cell body size↓ and cell body to cell size 
ratio ↓ 
 integrated optical density ↓ 
 levels of reactive  oxygen  species↓ at 1, 3, and 7 days 
after surgery, Malondialdehyde↓ at 1 and 3 days after 
surgery, and superoxide dismutase↑ at 1 day after 
surgery 
 expression of Fpn-1 ↓ at 1, 3, and 7 days after surgery, 
hepcidin ↓ at 1 and 3 days after surgery, DMT1 ↓ at 1 
and 3 days after surgery, and TfR ↑ at 1, 3, and 7 days 
after surgery  








(31)  Iron concentration in hippocampal ↓ 
 The expression of  CD68 ↓ and BDNF↑ 
 Levels of Fpn-1 ↑, hepcidin ↓, DMT1 ↓, TNF-α ↓, IL-
1β ↓, MDA↓ , and ROS↓ in the hippocampus 
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Dexmedetomidine: it has been used in 4 studies and its 
use in mice and rats undergoing surgery significantly 
reduced the expression of pro-inflammatory cytokines 
(33,35,40,47). In the study of Chen et al., No 
significant change was observed in IL-10 levels in the 
plasma and cortex region in treated rats receiving 
treatment (47).  
Neuronal apoptosis has also been studied in 3 
studies, which have been significantly reduced 
(47,35,33). Marker levels of IBA-1, Aβ, and Tau 
content and expression of BAX, BCL-2, and caspase-
3 were significantly decreased in the hippocampus and 
prefrontal cortex (33). In the study by Zhu et al., The 
results showed that the expression of GABABR1 and 
GABABR2 proteins were significantly reduced, while 
the expression of PKA, BDNF, and p-CREB proteins 
was significantly increased compared to rats 
undergoing surgery.  
It also improved neuronal arrangement and 
morphology in rats undergoing surgery with 
dexmedetomidine treatment (35). In another study, the 
number of doublecortin staining cells in the dg region 
of the hippocampus, protein, and BDNF gene 
expression, and p-CREB/CREB and PKA production 
increased significantly, and the p-MAPK /MAPK ratio 
decreased significantly (40). In the study of Chen et al., 
Plasma S100β and NSE levels significantly decreased 
Caspase-3, pJAK2, and pSTAT3 protein expression 
(47). 
Vitamin-rich carbohydrate: the results of the study of 
Zou et al. Showed that the use of vitamin-rich 
carbohydrates before surgery significantly reduces the 
expression and levels of biomarkers GRP78, eIF2a, 
Beclin-1, and Bax and significantly increases the level 
of BCL-2. The result is a reduction in endoplasmic 
reticulum (ER) stress and neuronal apoptosis, which 
reduces cognitive dysfunction resulting from surgery 
(34). 
Exendin-4: in the study, a significant decrease in the 
levels of pro-inflammatory cytokines, marker IBA-1, 
tau hyperphosphorylation in ser396 and ser199/202, as 
well as a significant increase in the expression of GLP-
1, GLP-1R and p-GSK-3β proteins in the hippocampus 
and synaptophysin were observed (36). 
Methane-rich saline: receiving this treatment in mice 
who underwent surgery significantly reduces the 
transcription and expression of pro-inflammatory 
cytokines such as TNF-α and IL-6. Also, the results of 
a study by Zhang et al. Show that receiving this 
treatment can reduce significant cell body-to-cell size 
ratio and phosphorylation of ERK, JNK, P38, and P65. 
Receiving this treatment also reduced the activity of 
IBA-1 markers (22). 
Honokiol: in two studies, the effect of this treatment 
on mice undergoing surgery was investigated. In both 
studies, neuronal apoptosis, expression levels of IBA-
1, IL‐1β, mitochondrial ROS, and malondialdehyde 
were significantly reduced (18,23) and showed a 
positive effect of Honokiol on the side effects of 
surgery and anesthesia. Expression levels of LC3-II, 
Beclin-1, PINK1, Parkin, NLRP3, ASC, Caspase-1, 
and IL-18 were significantly reduced by receiving 
Honokiol treatment (23). Expression levels of MCP‐1, 
Ac-SOD2, and cytochrome C levels decreased 
significantly, while sirt3 expression levels increased 
significantly and SOD2 expression levels did not 
change significantly (18). 
Ginsenoside Rg1: administration of Ginsenoside Rg1 
in mice undergoing surgery significantly increased 
ATP production, basal mitochondrial respiration and 
mitochondrial membrane potential, maximal 
mitochondrial respiratory capacity, and uncoupling, 
Sirt3 expression and deacetylation activity in these 
mice increased significantly, while ROS levels 
decreased significantly (24). 
Purmorphamine: the expression of Shh, LC3-II, LC3-
II / LC3-I proteins was significantly increased in rats 
treated with purmorphamine compared to rats that 
underwent surgery alone, while the expression of P62 
was decreased (37). 
Siegesbeckia Orientalis: two doses of high (1.5 g / kg) 
and low (0.75 g / kg) were used in operated mice. The 
regulation of pro-inflammatory cytokines such as IL-6 
and IL-1β was significantly reduced at high doses, 
while the effect of low doses was not positive and no 
significant change was achieved. High and low doses 
did not affect the regulation of IL-8 and TNF-α and no 
change was observed. The use of high doses of this 
treatment significantly reduced the phosphorylation of 
JNK and P65, while its low dose did not affect their 
phosphorylation. Both doses used significantly 
reduced tau phosphorylation. The results of this study 
indicate that low doses may not be very suitable for the 
treatment of complications of surgery and anesthesia in 
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contrast to high doses (25). 
Mycobacterium vaccine immunization: the results of 
using this strategy show that regulation of NFKBIA, 
expression of protein and gene of IL-1β and CD3 
mRNA significantly decreased as well as regulation of 
IL-4, Arginase1, and expression of Foxp3 mRNA 
significantly increased while this strategy does not 
affect CD4 mRNA expression (38). 
Emulsified form of resveratrol: 5 doses of 80 mg / kg, 
60 mg / kg, 40 mg / kg, 20 mg / kg and 2 mg / kg were 
used for this treatment. Doses of 80 mg/kg, 60 mg/kg, 
and 40 mg/kg were reduced there were significant 
levels of IL-1β and TNF-α, while the other two doses 
did not affect pro-inflammatory cytokines (39). 
Nicotine: at a dose of 0.5 mg/kg used in rats 
undergoing surgery nicotine could significantly reduce 
the expression of pro-inflammatory cytokines il-1β, 
TNF-α, HMGB-1, and NF-κB P65, and measurements 
of BDNF and p-TrkB expression showed a significant 
postoperative day Increased three days after surgery 
was not significantly different from rats that underwent 
surgery alone. Cleaved caspase-3 expression and 
neuronal apoptosis were also assessed one and three 
days after surgery and a significant decrease was 
observed (41). 
Nimodipine: in two studies, this treatment was used 
and the results show that this treatment significantly 
reduced neuronal apoptosis and the amount of (Ca2+)i 
in the hippocampus (45, 42). Can and caspase-3 
expression (42), Bax expression, and Bax/BCL-2 ratio 
(46) decreased significantly and BCL-2 mRNA 
expression also increased significantly (45).  
Lipopolysaccharide: if lipopolysaccharide is injected 
into mice 72 or 24 hours before surgery, it causes the 
number of IBA-1 markers and the level of pro-
inflammatory cytokines such as TNF‑α, IL-1β, IL-6 
significantly after Surgery is reduced if the level of 
pro-inflammatory post-inflammatory cytokines is not 
significantly different from that in mice that have 
undergone surgery alone if injected during surgery or 
6 hours before surgery. Preoperative 
lipopolysaccharide was not effective at the level of IL-
10 and its level was not significantly different from the 
group of mice that underwent surgery only (19). 
Brilliant Blue G: expression of P2X7 receptors, 
precursor caspase 1 and p20, and IBA-1 marker levels 
were significantly decreased in the DG and CA1 
regions of the hippocampus. 
Hydrogen molecule (H2): in the study of Xin et al., A 
hydrogen molecule with a concentration of 2% was 
used to treat and improve the complications of surgery 
and anesthesia in rats. The results of this study show 
that the use of H2 can increase caspase-3 activity and 
cytokine levels. Significantly reduce pro-inflammatory 
IL-1β, IL-6, and HMGB1 in serum and hippocampus 
after surgery. H2 did not affect TNF-α level in serum 
and hippocampus (43). 
Hydrogen-rich saline: saline-rich hydrogen at a dose 
of 10 mg/kg significantly reduced TNF-α and IL-1β 
levels and NF-κB activity in the hippocampus. The 
light density of TNF-α and IL-1β was also significantly 
reduced in the hippocampus (27). 
Edaravone: the use of this treatment after abdominal 
surgery significantly reduced neuronal death and 
neuroapoptosis in the hippocampus, and also 
significantly reduced GRP78 and chop expression with 
edaravone (28). 
α7nAchR agonist PHA568487: neuronal apoptosis in 
the hippocampus, caspase-3 expression, and serum 
levels of S100β, TNF-α, and il-6 were significantly 
reduced under the influence of α7nachr agonist 
PHA568487. The expression of p-Akt and p-GSK3β 
was also significantly increased, while the treatment 
used in this study did not affect the total levels of Akt 
and GSK3β (44). 
Hypertonic saline 7/5%: use of this treatment after 
surgery significantly reduced neuronal apoptosis and 
(Ca2+)i in the hippocampus, and significantly 
decreased Bax mRNA expression, and significantly 
increased BCL-2 mRNA expression (45). 
Glycyrrhizin: levels of HMGB1, TLR4, il-1β, TNF-α, 
BACE1, IL-6, nuclear and cytosolic protein NF-κB in 
the hippocampus of elderly mice were significantly 
reduced by the effect of glycyrrhizin after 
splenectomy, PSD95 expression was also significantly 
in mice Elderly levels increased significantly but 
glycyrrhizin had no effect on synapsin I expression 
(29). 
Pyrrolidine dithiocarbamate: the use of Pyrrolidine 
dithiocarbamate significantly reduced GDNF 
concentrations in rats undergoing surgery while not 
affect BDNF concentrations. IBA-1 marker expression 
was also significantly decreased under the influence of 
the treatment used (46). 
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Minocycline: the levels of IL-1β, TNF-α, IFN-γ, IBA-
1 were significantly reduced and the levels of IL-4 and 
il-10 were significantly increased by the dose of 45 
mg/kg of minocycline (30). 
Deferoxamine: the effects of this drug at a dose of 100 
mg/kg were evaluated in two studies and the 
concentrations of iron, hepcidin, DMT1, 
malondialdehyde, reactive oxygen species (ROS) in 
the hippocampus were significantly reduced (31,48). 
The level of Fpn-1 increased significantly in the study 
of Li et al. (31) while in the study of Pan et al. It 
decreased significantly (48). BDNF expression 
increased significantly and CD68 and TNF-α and IL-
1β levels in the hippocampus decreased significantly 
(31). The expression of ferritin, caspase-3, Bax, 
integrated optical density and average cell body size, 
cell body to cell size ratio decreased significantly while 
the expression of TfR and BCL-2 increased 
significantly (48).  
 
Conclusion 
Postoperative brain injuries are caused by anesthetics 
and surgery. Postoperative neurological defects can 
cause cognitive dysfunction (4, 49). The probability of 
cognitive dysfunction after cardiovascular surgery is 
between 28 to 100% and after general surgery is 
usually between 7 to 28% (50-52).  
Postoperative brain damage remains a major 
problem because it can increase mortality among 
patients. The purpose of this systematic review study, 
written according to Prism guidelines, is to evaluate the 
effectiveness of drug strategies to reduce surgical brain 
damage.  
By searching for keywords in databases, we 
selected studies that met the input criteria after careful 
review and extracted their information. Findings from 
these studies show that mice and rats that receive 
medication before and after surgery can improve 
neuritis and brain damage compared to mice and rats 
that receive surgery alone, and therefore can reduce 
side effects from surgery and anesthetics. For more 
detailed studies, it is necessary to conduct human 
studies in this field to be able to comment more 
confidently on the effect of drugs on side effects after 
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NFKBIA: nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha; FOXP3: 
forkhead box P3; IL: interleukin; IBA-1: ionized 
calcium-binding adapter molecule 1; MAPKs: 
mitogen-activated-protein kinases; MLKs: Mixed-
lineage kinases; JNK: c Jun amino-terminal kinase; 
SYN: synaptophysin; PSD95: postsynaptic density 
protein 95; KYNA: kynurenic acid; QUIN: quinolinic 
acid; TNF-α: tumor necrosis factor-α; Aβ: amyloid β-
protein; GRP-78: glucose-regulated protein 78; eIF2a: 
eukaryotic translation initiation factor 2 subunit a; ER: 
endoplasmic reticulum; GABABR: γ-amino butyric 
acid-B receptor; PKA: protein kinase A; cAMP: cyclic 
adenosine monophosphate; CREB: cAMP-response 
element binding; BDNF: brain-derived neurotrophic 
factor; LPS: lipopolysaccharide; GLP-1: glucagon-like 
peptide 1; GLP-1R: glucagon-like peptide 1 receptor; 
MDA: malondialdehyde; ROS: reactive oxygen 
species; SIRT3: Sirtuin3; SOD2: superoxide dismutase 
2; ATP: Adenosine triphosphate; FOXP3:  forkhead 
box P3; DCX: doublecortin staining; HMGB-1: high 
mobility group box-1; CaN: Calcineurin; CHOP: 
CCAAT-enhancer-binding homologous protein; 
GSK3β: glycogen synthase kinase 3β; p- GSK3β: 
phosphorylated glycogen synthase kinase 3β; BACE1 
Beta-secretase 1; TLR4: Toll-like receptor 4; GDNF: 
glial cell-derived neurotrophic factor; BrdU: 5′-bromo-
2′-deoxyuridine; NeuN: neuronal nuclei, Bcl-2: B cell 
lymphoma 2; Bax: Bcl-2 associated X protein; Fpn1: 
ferroportin 1; DMT1: divalent metal transporter 1; 
TfR: transferrin receptor.. 
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Section/topic  # Checklist item  
Reported 
on page # 
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
1 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  1-2 
Objectives  4 Provide an explicit statement of questions being addressed regarding participants, interventions, comparisons, outcomes, and 
study design (PICOS).  
2 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration 
information including registration number.  
2 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale.  
3 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
2 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.  2 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in the systematic review, and, if applicable, 
included in the meta-analysis).  
2-3 
Data collection process  10 Describe the method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
3 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
3 
Risk of bias in individual 
studies  
12 Describe methods used for assessing the risk of bias of individual studies (including specification of whether this was done at 
the study or outcome level), and how this information is to be used in any data synthesis.  
3 
Summary measures  13 State the principal summary measures (e.g., risk ratio, the difference in means).  - 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) 
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Risk of bias across studies  15 Specify any assessment of the risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
3 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
- 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
3 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
3 
Risk of bias within studies  19 Present data on the risk of bias of each study and, if available, any outcome level assessment (see item 12).  - 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
3-9 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  - 
Risk of bias across studies  22 Present results of any assessment of the risk of bias across studies (see Item 15).  - 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
- 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policymakers).  
9 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
- 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence and implications for future 
research.  
9 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., the supply of data); the role 
of funders for the systematic review.  
- 
The PRISMA statement is based on the model from Moher, et al. (53). For more information, visit www.prisma-statement.org.
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